Lv11
80 积分 2022-05-04 加入
Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
2个月前
已完结
Safety and Efficacy of Dulaglutide, a Once Weekly GLP-1 Receptor Agonist, for the Management of Type 2 Diabetes
7个月前
已关闭
Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate Degradation
8个月前
已完结
Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody
8个月前
已完结
The Evolution of Commercial Antibody Formulations
11个月前
已完结
Aggregation Time Machine: A Platform for the Prediction and Optimization of Long-Term Antibody Stability Using Short-Term Kinetic Analysis
1年前
已完结
High concentration formulation developability approaches and considerations
1年前
已完结
Effects of arginine in therapeutic protein formulations: a decade review and perspectives
1年前
已完结
Conformational Changes and Drivers of Monoclonal Antibody Liquid-Liquid Phase Separation
1年前
已完结
皖公网安备34019202002308
